Global medtech leader Medtronic plc has announced a strategic investment of USD 50 million (approximately Rs. 430 crore) over five years to establish and expand a new Global Capability Centre (GCC) in Pune, India, focused exclusively on its diabetes business. The facility, unveiled this week, will serve as a hub for software development, service operations, and patient financial solutions.